Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2004; 129: S63-S65
DOI: 10.1055/s-2004-831374
DOI: 10.1055/s-2004-831374
Kurzübersicht
Leber
© Georg Thieme Verlag Stuttgart · New York
Aszites - Diagnostik und Therapie
Diagnosis and treatment of ascitesFurther Information
Publication History
eingereicht: 5.5.2004
akzeptiert: 13.8.2004
Publication Date:
15 September 2004 (online)
Glossar
ADH = Antidiuretisches Hormon
HRS = hepatorenales Syndrom
RAAS = Renin-Angiotensin-Aldosteronsystem
SNS = sympathisches Nervensystem
SBP = spontane bakterielle Peritonitis
TIPS = transjugulärer intrahepatischer portosystemischer Shunt
Literatur
- 1 Angeli P, Volpin R, Gerunda G. et al . Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology. 1999; 29 1690-1697
- 2 Arroyo V, Gines P, Gerbes A L. et al . Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology. 1996; 23 164-176
- 3 Brensing K A, Textor J, Perz J. et al . Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut. 2000; 47 288-295
- 4 Ginès A, Escorsell A, Ginès P. et al . Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 1993; 105 229-236
- 5 Gines P, Tito L, Arroyo V. et al . Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology. 1988; 94 1493-1502
- 6 Gonwa T A, Klintmalm G B, Levy M. et al . Impact of pretransplant renal function on survival after liver transplantation. Transplantation. 1995; 15 (59) 361-365
- 7 Gülberg V, Bilzer M, Gerbes A L. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology. 1999; 30 870-875
- 8 Gülberg V, Gerbes A L. Diagnostik und Therapie des Aszites bei Leberzirrhose. Internist (Berl.). 1998; 39 254-262
- 9 Gülberg V, Liss I, Bilzer M. et al . Improved quality of life in patients with refractory or recidivant ascites after insertion of transjugular intrahepatic portosystemic shunts. Digestion. 2002; 66 127-130
- 10 Moreau R, Durand F, Poynard T. et al . Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology. 2002; 122 923-930
- 11 Restuccia T, Ortega R, Guevara M. et al . Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol. 2004; 40 140-146
- 12 Rössle M, Ochs A, Gülberg V. et al . A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000; 342 1701-1707
- 13 Schrier R W, Arroyo V, Bernardi M. et al . Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988; 8 1151-1157
- 14 Sort P, Navasa M, Arroyo V. et al . Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999; 341 403-409
Prof. Dr. med. Alexander L. Gerbes
Ludwig-Maximilians-Universität München, Medizinische Klinik II
Marchioninistraße 15
81366 München
Phone: (0 89) 70 95-22 92
Fax: (0 89) 70 95-23 92
Email: gerbes@med2.med.uni-muenchen.de